Nissin Medical Industries Co. Ltd
Nissin Medical Industries Co. Ltd., commonly referred to as Nissin, is a prominent player in the medical equipment industry, headquartered in Japan. Established in 1950, the company has made significant strides in the development and manufacturing of high-quality medical devices, particularly in the field of wheelchairs and mobility aids. With a strong operational presence across Asia and beyond, Nissin is renowned for its innovative approach to enhancing patient mobility and comfort. Their core products, including advanced wheelchairs and rehabilitation equipment, are distinguished by their ergonomic design and cutting-edge technology. Nissin's commitment to quality and user-centric solutions has solidified its market position, making it a trusted name among healthcare professionals and patients alike. The company continues to set benchmarks in the industry, reflecting its dedication to improving the lives of individuals with mobility challenges.
DitchCarbon Score
How does Nissin Medical Industries Co. Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Motor Vehicle Retail Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Nissin Medical Industries Co. Ltd's score of 13 is lower than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Nissin Medical Industries Co. Ltd's reported carbon emissions
In 2019, Nissin Medical Industries Co. Ltd reported total carbon emissions of approximately 16,252,000 kg CO2e from Scope 1, 14,403,000 kg CO2e from Scope 2, and 2,961,000 kg CO2e from Scope 3. This reflects a slight decrease in Scope 1 emissions compared to 2018, where emissions were about 16,559,000 kg CO2e, and a notable increase in Scope 2 emissions from 12,537,000 kg CO2e in the same year. The company's emissions data from previous years shows a consistent trend, with Scope 1 emissions peaking at about 16,590,000 kg CO2e in 2018 and Scope 2 emissions reaching a high of 14,403,000 kg CO2e in 2019. Scope 3 emissions have also fluctuated, with the highest recorded at approximately 2,961,000 kg CO2e in 2019. Despite these figures, Nissin Medical Industries has not publicly disclosed specific reduction targets or initiatives aimed at decreasing their carbon footprint. The absence of documented climate pledges or science-based targets indicates a potential area for improvement in their sustainability strategy. As the industry increasingly prioritises climate action, Nissin Medical Industries may benefit from establishing clear commitments to reduce emissions across all scopes.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2016 | 2017 | 2018 | 2019 | |
|---|---|---|---|---|---|
| Scope 1 | 15,988,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 12,207,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 2,939,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Nissin Medical Industries Co. Ltd is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
